Alzecure: Outcome of rights issue – Redeye
Redeye comments on the outcome of Alzecures oversubscribed rights issue and reiterate our base case for now.
Redeye
Redeye comments on the outcome of Alzecures oversubscribed rights issue and reiterate our base case for now.
Redeye